Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice

We evaluated the efficacy of a neutralizing anti-high mobility group box 1 (HMGB1) monoclonal antibody in MRL/lpr lupus-prone mice. The anti-HMGB1 monoclonal antibody (5 mg/kg weight) or class-matched control immunoglobulin G2a (IgG2a) was administered intravenously twice a week for 4–15 weeks. Urin...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Haruki, Watanabe, Katsue S., Liu, Keyue, Hiramatsu, Sumie, Zeggar, Sonia, Katsuyama, Eri, Tatebe, Noriko, Akahoshi, Akiya, Takenaka, Fumiaki, Hanada, Takahisa, Akehi, Masaru, Sasaki, Takanori, Sada, Ken-ei, Matsuura, Eiji, Nishibori, Masahiro, Wada, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472134/
https://www.ncbi.nlm.nih.gov/pubmed/28649578
http://dx.doi.org/10.1016/j.omtm.2017.05.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472134/
https://www.ncbi.nlm.nih.gov/pubmed/28649578
http://dx.doi.org/10.1016/j.omtm.2017.05.006

Ejemplares similares